Fármacos antiangiogénicos en enfermedades neovasculares de la retina

摘要: An Increased vascular endothelial growth factor in degenerative, obstructive and even neoplastic processes is the main pathophysiological mechanism for formation of aberrant blood vessels, which are detrimental put at risk visual acuity individual. In recent years, creation antiangiogenic (anti-VEGF) drugs their intravitreal use have revolutionized therapy retinal neovascular diseases provided an increase quality life people suffering from it. The following narrative review article seeks to analyze safety, efficacy, posology, route administration international regimens anti-VEGF treatment Exudative Age- Associated Macular Degeneration (AMD), Diabetic Oedema (DME), Occlusion Central Retina Vein (CRVO), Retinal Venous Branch (BRVO) Retinoblastoma. intraocular represents a safe effective choice pathologies.